N-[3-Chloro-2-(piperidin-1-yl)phenyl]-3-nitrobenzamide

Catalog No.: 
ACTZOB366
CAS No.: 
383145-58-2
Molecular Formula: 
C18H18ClN3O3
Molecular Weight: 
359.81
N-[3-Chloro-2-(piperidin-1-yl)phenyl]-3-nitrobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$186.00InquiryInquiry
1g90%$563.00InquiryInquiry
5g90%$2787.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[3-Chloro-2-(piperidin-1-yl)phenyl]-3-nitrobenzamide
IUPAC NameN-(3-chloro-2-(piperidin-1-yl)phenyl)-3-nitrobenzamide
MDL No.MFCD03011882
Molecular FormulaC18H18ClN3O3
Molecular Weight359.81
SMILESO=C(NC1=CC=CC(Cl)=C1N2CCCCC2)C3=CC=CC([N+]([O-])=O)=C3
InChI KeyHZRSWLXYPHORCJ-UHFFFAOYSA-N
SynonymN-(3-CHLORO-2-PIPERIDINOPHENYL)-3-NITROBENZENECARBOXAMIDE;Benzamide, N-[3-chloro-2-(1-piperidinyl)phenyl]-3-nitro-
CAS No.383145-58-2

Synthetic Route by SureRoute

1. ACTZOB366 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPWAX062 route compound structure diagram
    ACPWAX0622445786-59-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZOB366 route product structure diagram
    ACTZOB366383145-58-2
Inquiry

2. ACTZOB366 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPWAX062 route compound structure diagram
    ACPWAX0622445786-59-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZOB366 route product structure diagram
    ACTZOB366383145-58-2
Inquiry

3. ACTZOB366 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVOGY526 route compound structure diagram
    ACVOGY526618-95-1In Stock
  2. Plus
  3. ACPWAX062 route compound structure diagram
    ACPWAX0622445786-59-2In Stock
  4. Then
  5. ACTZOB366 route product structure diagram
    ACTZOB366383145-58-2
Inquiry

Comments (0)